12/12/17 -"Just how long can a good thing last? Not unto eternity, if fundamentals have their say. Riding on the coattails of its first cousin, pharma (and thriving on its miseries), the recent rally in Med-tech seems to have run its course. This study captures why the sector makes for slim pickings at current levels and why a slowdown...or more accurately…a correction... is imminent. Our Lead Analyst Jyoti Prakash has published her latest note entitled " EUROPEAN MEDTECH: A correction is imminent". "